Inosine monophosphate dehydrogenase activity as a biomarker of mycophemolic acid effects in pediatric kidney transplant recipients.

被引：0
|
作者：
Thogersen, H. [1 ]
Goebel, J. [2 ]
Cox, S. [3 ]
Maseck, D. [3 ]
Logan, B. [2 ]
Vinks, A. A. [3 ]
机构：
[1] Univ Oslo, Oslo, Norway
[2] Dept Nephrol, Cincinnati, OH USA
[3] Childrens Hosp Med Ctr, Cincinnati, OH USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [31] Conversion to mycophenolate mofetil (MMF) in pediatric kidney transplant recipients.
    Machado, PGP
    Nogueira, PCK
    Park, SI
    Tedesco-Silva, H
    Pestana, JOM
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 92 - 92
  • [32] Consistent High Burden of Arteriosclerosis in Pediatric Kidney Transplant Recipients.
    Ostendorf, K.
    Memaran, N.
    Borchert-Morlins, B.
    von der Born, J.
    Bauer, E.
    von Wick, A.
    Oh, J.
    Kemper, M. J.
    Buescher, R.
    Schmidt, B. M.
    Melk, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 975 - 976
  • [33] Alemtuzumab preconditioning and tacrolimus monotherapy in pediatric kidney transplant recipients.
    Shapiro, Ron
    Ellis, Demetrius
    Tan, Henkie P.
    Moritz, Michael L.
    Basu, Amit
    Vats, Abhay N.
    Kayler, Liise K.
    Erkan, Elif
    McFeaters, Corde G.
    James, Gerri
    Grosso, Mary J.
    Zeevi, Adriana
    Gray, Edward A.
    Marcos, Amadeo
    Starzl, Thomas E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 188 - 188
  • [34] Effects of Paricalcitol On Bone Turnover in Kidney Transplant Recipients.
    Amer, H.
    Griffin, M.
    Ryan, Z.
    Park, W.
    Kremers, W.
    Stegall, M.
    Cosio, F.
    Kumar, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 882 - 882
  • [35] Effects of Paricalcitol On Bone Turnover in Kidney Transplant Recipients.
    Amer, H.
    Griffin, M.
    Ryan, Z.
    Park, W.
    Kremers, W.
    Stegall, M.
    Cosio, F.
    Kumar, R.
    TRANSPLANTATION, 2014, 98 : 882 - 882
  • [36] Optimization and application of an HPLC method for quantification of inosine-5′-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients
    Liu, Feiyan
    Xu, Luyang
    Sheng, Changcheng
    Qiu, Xiaoyan
    Zhang, Ming
    Jiao, Zheng
    CLINICA CHIMICA ACTA, 2018, 485 : 333 - 339
  • [37] Measurement of plasma mycophenolic acid in pediatric renal transplant recipients.
    McBride, JH
    Kim, S
    Reyes, A
    Rodgerson, DO
    CLINICAL CHEMISTRY, 1998, 44 : A93 - A93
  • [38] Unexpected Early Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
    Yanik, M.
    Mannon, R.
    Seifert, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 750 - 750
  • [39] Extended Valganciclovir Prophylaxis Is Well Tolerated in Pediatric Kidney Transplant Recipients.
    Benchimol, C.
    Tedesco Silva, H., Jr.
    Varela-Fascinetto, G.
    Genevray, M.
    Bradley, D.
    Ives, J.
    TRANSPLANTATION, 2014, 98 : 497 - 497
  • [40] Critical analysis of outcomes in high risk pediatric kidney transplant recipients.
    Weimert, Nicole A.
    Taber, Dave J.
    Chavin, Kenneth D.
    Hammond, Emily B.
    Henderson, Francine
    Lin, Angello
    Bratton, Charles F.
    McGillicuddy, John
    Ayiku, Henry
    Henderson, Francine
    Baliga, Prabhakar K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 368 - 369
12345